{"entity":{"id":"nct06885281","kind":"trial","name":"A Study of ZL-1310 in Participants With Selected Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of ZL-1310 in advanced solid tumours, run by Zai Lab (Shanghai) Co., Ltd., now recruiting.","summary":"A Study of ZL-1310 in Participants With Selected Solid Tumors is a phase 1/2 interventional study registered as NCT06885281 by Zai Lab (Shanghai) Co., Ltd., with 166 participants planned, started 2025-05-12 and due to reach its primary completion in 2027-08. Interventions recorded: ZL-1310.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06885281","url":"https://clinicaltrials.gov/study/NCT06885281"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["zl-1310"],"companies":["zai-lab"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06885281","phase":"1/2","setting":"A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors","sponsor":"Zai Lab (Shanghai) Co., Ltd.","enrolled":166,"outcomes":[]},"route":"/trials/nct06885281/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"zl-1310","kind":"drug","name":"ZL-1310","route":"/drugs/zl-1310/"}],"company":[{"id":"zai-lab","kind":"company","name":"Zai Lab","route":"/companies/zai-lab/"}]}}